Hawaii 2025 Regular Session

Hawaii House Bill HR174 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	HOUSE OF REPRESENTATIVES H.R. NO. 174 THIRTY-THIRD LEGISLATURE, 2025 STATE OF HAWAII HOUSE RESOLUTION recognizing February 3 as Topical Steroid Withdrawal Syndrome Awareness Day.
2	2
3	3	HOUSE OF REPRESENTATIVES H.R. NO. 174
4	4	THIRTY-THIRD LEGISLATURE, 2025
5	5	STATE OF HAWAII
6	6
7	7	HOUSE OF REPRESENTATIVES
8	8
9	9	H.R. NO.
10	10
11	11	174
12	12
13	13	THIRTY-THIRD LEGISLATURE, 2025
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29	HOUSE RESOLUTION
30	30
31	31
32	32
33	33
34	34
35	35	recognizing February 3 as Topical Steroid Withdrawal Syndrome Awareness Day.
36	36
37	37
38	38
39	39
40	40
41	41
42	42
43	43	WHEREAS, Topical Steroid Withdrawal Syndrome, also known as Topical Steroid Addiction or Red Skin Syndrome, is a severe, debilitating condition that can arise from intentional or unintentional exposure to topical steroids; and WHEREAS, topical steroids are widely prescribed and purchased over the counter to treat acute and chronic skin conditions, such as eczema, psoriasis, vitiligo, and alopecia areata; and WHEREAS, Topical Steroid Withdrawal Syndrome is characterized by skin flushing, inflammation, diffuse spreading rashes, profuse skin flaking, burning, and itching worse than the original condition, which typically appear after the use of topical steroid treatments, between treatments, or after discontinuing the use of topical steroids; and WHEREAS, it can take several months to several years for symptoms to subside, leaving some sufferers of Topical Steroid Withdrawal Syndrome bedridden, housebound, and unable to work, care for children, or attend school; and WHEREAS, a prolonged withdrawal and recovery period can take a significant toll on patients' mental health as well as physical health; and WHEREAS, eighty-one percent of adults and fifty-six percent of children who experience Topical Steroid Withdrawal Syndrome report feeling anxious or depressed, and forty-seven percent of adults and eleven percent of children who experience Topical Steroid Withdrawal Syndrome report suicidal ideation; and WHEREAS, the prevalence of topical steroid addiction and Topical Steroid Withdrawal Syndrome are unknown due to a scarcity of published research, and the paucity of research on Topical Steroid Withdrawal Syndrome impedes efforts to define diagnostic criteria for this condition; understand its causes, mechanics, and effects; develop appropriate treatment protocols; and educate providers and patients about Topical Steroid Withdrawal Syndrome and proper steroid stewardship; and WHEREAS, a lack of awareness of and education about Topical Steroid Withdrawal Syndrome can lead to misunderstanding and friction between patients and providers, causing patients to question their providers' medical oversight and providers to suspect their patients of medication non-compliance and, occasionally, parental neglect; and WHEREAS, all parties would benefit greatly from increased awareness of and prevention education on the signs of topical steroid dependence and the risks of Topical Steroid Withdrawal Syndrome; now, therefore, BE IT RESOLVED by the House of Representatives of the Thirty-third Legislature of the State of Hawaii, Regular Session of 2025, that February 3 is recognized as Topical Steroid Withdrawal Syndrome Awareness Day; and BE IT FURTHER RESOLVED that a certified copy of this Resolution be transmitted to the Governor. OFFERED BY: _____________________________
44	44
45	45	WHEREAS, Topical Steroid Withdrawal Syndrome, also known as Topical Steroid Addiction or Red Skin Syndrome, is a severe, debilitating condition that can arise from intentional or unintentional exposure to topical steroids; and
46	46
47	47
48	48
49	49	WHEREAS, topical steroids are widely prescribed and purchased over the counter to treat acute and chronic skin conditions, such as eczema, psoriasis, vitiligo, and alopecia areata; and
50	50
51	51
52	52
53	53	WHEREAS, Topical Steroid Withdrawal Syndrome is characterized by skin flushing, inflammation, diffuse spreading rashes, profuse skin flaking, burning, and itching worse than the original condition, which typically appear after the use of topical steroid treatments, between treatments, or after discontinuing the use of topical steroids; and
54	54
55	55
56	56
57	57	WHEREAS, it can take several months to several years for symptoms to subside, leaving some sufferers of Topical Steroid Withdrawal Syndrome bedridden, housebound, and unable to work, care for children, or attend school; and
58	58
59	59
60	60
61	61	WHEREAS, a prolonged withdrawal and recovery period can take a significant toll on patients' mental health as well as physical health; and
62	62
63	63
64	64
65	65	WHEREAS, eighty-one percent of adults and fifty-six percent of children who experience Topical Steroid Withdrawal Syndrome report feeling anxious or depressed, and forty-seven percent of adults and eleven percent of children who experience Topical Steroid Withdrawal Syndrome report suicidal ideation; and
66	66
67	67
68	68
69	69	WHEREAS, the prevalence of topical steroid addiction and Topical Steroid Withdrawal Syndrome are unknown due to a scarcity of published research, and the paucity of research on Topical Steroid Withdrawal Syndrome impedes efforts to define diagnostic criteria for this condition; understand its causes, mechanics, and effects; develop appropriate treatment protocols; and educate providers and patients about Topical Steroid Withdrawal Syndrome and proper steroid stewardship; and
70	70
71	71
72	72
73	73	WHEREAS, a lack of awareness of and education about Topical Steroid Withdrawal Syndrome can lead to misunderstanding and friction between patients and providers, causing patients to question their providers' medical oversight and providers to suspect their patients of medication non-compliance and, occasionally, parental neglect; and
74	74
75	75
76	76
77	77	WHEREAS, all parties would benefit greatly from increased awareness of and prevention education on the signs of topical steroid dependence and the risks of Topical Steroid Withdrawal Syndrome; now, therefore,
78	78
79	79
80	80
81	81	BE IT RESOLVED by the House of Representatives of the Thirty-third Legislature of the State of Hawaii, Regular Session of 2025, that February 3 is recognized as Topical Steroid Withdrawal Syndrome Awareness Day; and
82	82
83	83
84	84
85	85	BE IT FURTHER RESOLVED that a certified copy of this Resolution be transmitted to the Governor.
86	86
87	87
88	88
89	89
90	90
91	91
92	92
93	93	OFFERED BY: _____________________________
94	94
95	95
96	96
97	97	OFFERED BY:
98	98
99	99	_____________________________
100	100
101	101
102	102
103	103
104	104
105	105
106	106
107	107	Report Title: Topical Steroid Withdrawal Syndrome Awareness Day; February 3
108	108
109	109	Report Title:
110	110
111	111	Topical Steroid Withdrawal Syndrome Awareness Day; February 3